Key Segmentation
By Offering
-
Software & Platforms
-
Hardware & Connected Equipment
-
Services
By Type
-
Manufacturing Execution & Electronic Batch Records
-
Automation & Process Control
-
Process Analytical Technology & Real-time Monitoring
-
Digital Twins, Modeling & Simulation
-
AI, Machine Learning & Advanced Analytics
-
Bioprocess Data Management & Integration
-
Quality & Laboratory Informatics
-
Others
By Application
-
Process Development & Scale-up
-
Commercial GMP Manufacturing Execution
-
Real-time Process Monitoring & Control
-
Quality Management & Batch Release
-
Technology Transfer & Facility Digitalization
-
Others
By End User
-
Pharmaceuticals & Biotechnology Companies
-
Academic & Research Institutes
-
CMOs & CDMOs
-
Others
Others Request for Segment Customization as per your Business Requirement
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Request for Country Level Research Report
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
North America dominated the digital biomanufacturing market in 2025 due to strong biopharmaceutical infrastructure, AI adoption, automation, and regulatory support.
The Software & Platforms segment dominated the market in 2025 due to high adoption of manufacturing execution systems, electronic batch records, and integrated data platforms enabling real time monitoring and regulatory compliance in biomanufacturing operations.
The major growth factors include increasing adoption of AI driven bioprocess optimization, rising demand for biologics, digital transformation in pharma manufacturing, use of digital twins, and focus on compliance and efficiency.
The digital biomanufacturing market was valued at USD 23.16 billion in 2025.